# Cardiac MRI Biomarker Testing (GCC 1618)

> **NCT02688166** · — · TERMINATED · sponsor: **University of Maryland, Baltimore** · enrollment: 6 (actual)

## Conditions studied

- Breast Cancer
- Lung Cancer (Non-Small Cell)
- Thoracic Cancer
- Thymic Cancer
- Mesothelioma

## Interventions

- **OTHER:** Complete Cardiac Magnetic Resonance Imaging (MRI)

## Key facts

- **NCT ID:** NCT02688166
- **Lead sponsor:** University of Maryland, Baltimore
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2018-02-01
- **Primary completion:** 2022-09-09
- **Final completion:** 2022-09-09
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Unable to meet accrual goal
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02688166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02688166, "Cardiac MRI Biomarker Testing (GCC 1618)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02688166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*